Search results

Jump to navigation Jump to search

Page title matches

Page text matches

  • |image=[[Image:rivaroxaban.png|center|thumb|350px]] |molname=rivaroxaban
    4 KB (500 words) - 14:12, 2 February 2023
  • ...|author=Kakkar AK, Brenner B, Dahl OE, ''et al'' |title=Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism a ...associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagon
    20 KB (2,687 words) - 13:56, 10 February 2015
  • : Then chemified [[Rivaroxaban]] and started [[dexamethasone]]. [[User:David E. Volk|David E. Volk]] 23:42
    11 KB (1,691 words) - 05:02, 8 March 2024
  • ...sachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H et al.| title=Oral rivaroxaban for symptomatic venous thromboembolism. | journal=N Engl J Med | year= 2010 | [[Randomized controlled trial]]<ref name="pmid21128814"/>|| Rivaroxaban for 6-12 months||1% over 6-12 months||7% over 6-12 months||0.7% major bleed
    29 KB (3,995 words) - 11:45, 2 February 2023
  • ...hor=Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W et al.| title=Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation. | journal=N Engl J Med | ROCKET AF<ref name="pmid21830957"/><br/>2011|| 14,264 patients|| [[Rivaroxaban]] 20 mg daily<br/>(15 mg daily if [[creatinine clearance]] 30 to 49 ml per
    32 KB (4,336 words) - 20:38, 2 February 2015
  • ...evier.com/retrieve/pii/S0140-6736(08)60880-6 |issn=}} (this trial compared rivaroxaban to short-term enoxaparin</ref> ...study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: t
    71 KB (9,981 words) - 10:49, 8 March 2024